For: | Zhang Q, Li ZQ, Liu H, Yang JH. Adenovirus-expressed preS2 antibody inhibits hepatitis B virus infection and hepatic carcinogenesis. World J Gastroenterol 2012; 18(4): 349-355 [PMID: 22294841 DOI: 10.3748/wjg.v18.i4.349] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i4/349.htm |
Number | Citing Articles |
1 |
Ziheng Ye, Su Zeng, Peipei Xu, Wenfei Liu, Shoufei Wang, Xiaotian Xia, Changqing Su, Minggao Guo. The Strategy of Conditionally Replicating Adenovirus-Mediated PreS2 Mini-Antibody Expression Has Dual Effects of Inhibiting HBV Infection and Preventing Hepatocellular Carcinoma. Cancer Management and Research 2021; : 1869 doi: 10.2147/CMAR.S298331
|
2 |
Huizhen Sun, Le Chang, Ying Yan, Lunan Wang. Hepatitis B virus pre‐S region: Clinical implications and applications. Reviews in Medical Virology 2021; 31(4) doi: 10.1002/rmv.2201
|
3 |
Yongbin Zeng, Chenggong Zhu, Er Huang, Zhen Xun, Yanfang Zhang, Tianbin Chen, Caorui Lin, Ya Fu, Songhang Wu, Bin Yang, Qishui Ou, Can Liu. Detection of serum large and middle hepatitis B virus surface proteins: A novel potential diagnostic and prognostic biomarker for chronic hepatitis B. Clinica Chimica Acta 2024; 553: 117739 doi: 10.1016/j.cca.2023.117739
|